Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref‐1 in thyroid cancer cells: A novel tumorigenic pathway
暂无分享,去创建一个
Andrea Scaloni | Sebastiano Filetti | Giuseppe Damante | A. Scaloni | C. Vascotto | G. Tell | S. Filetti | G. Damante | E. Ferretti | A. Pines | N. Bivi | M. Romanello | F. Quadrifoglio | C. D'Ambrosio | Gianluca Tell | Elisabetta Ferretti | R. Morisi | Carlo Vascotto | Nicoletta Bivi | Chiara D'Ambrosio | Alex Pines | Milena Romanello | Franco Quadrifoglio | Roberta Morisi | C. D’Ambrosio | Nicoletta Bivi | Chiara D’Ambrosio
[1] G Burnstock,et al. Is there a basis for distinguishing two types of P2-purinoceptor? , 1985, General pharmacology.
[2] Peter E. M. Butler,et al. P2Y purinergic receptors regulate the growth of human melanomas. , 2005, Cancer letters.
[3] P. Ping,et al. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. , 1999, The American journal of physiology.
[4] G. Burnstock,et al. Regulation of bone resorption and formation by purines and pyrimidines. , 2003, Trends in pharmacological sciences.
[5] G. Tell,et al. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? , 2005, Antioxidants & redox signaling.
[6] Z. Naito,et al. Expression of hsp90 and cyclin D1 in human breast cancer. , 1999, Cancer letters.
[7] J. Hescheler,et al. Activation of p90RSK and growth stimulation of multicellular tumor spheroids are dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] L. Oberley,et al. Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells. , 2003, American journal of physiology. Heart and circulatory physiology.
[9] D. Erlinge,et al. Tyrphostin inhibition of ATP‐stimulated DNA synthesis, cell proliferation and Fos‐protein expression in vascular smooth muscle cells , 1996, British journal of pharmacology.
[10] Vijaya R Arjunan,et al. Extracellular ATP activates c‐jun N‐terminal kinase signaling and cell cycle progression in hepatocytes , 2004, Hepatology.
[11] W. Fang,et al. ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. , 2004, Cancer letters.
[12] F. Di Virgilio,et al. Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. , 2005, Endocrinology.
[13] J. Simon,et al. Mechanisms of P2 receptor‐evoked DNA synthesis in thyroid FRTL‐5 cells , 2001, Journal of cellular physiology.
[14] R. Hipskind,et al. Signaling in Human Osteoblasts by Extracellular Nucleotides , 1999, The Journal of Biological Chemistry.
[15] R. Rodnight,et al. ERK, PKC and PI3K/Akt Pathways Mediate Extracellular ATP and Adenosine-Induced Proliferation of U138-MG Human Glioma Cell Line , 2005, Oncology.
[16] G Burnstock,et al. Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.
[17] G. Burnstock,et al. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[18] D. Erlinge. Extracellular ATP: a growth factor for vascular smooth muscle cells. , 1998, General pharmacology.
[19] I. Novak. ATP as a signaling molecule: the exocrine focus. , 2003, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[20] M. Gulisano,et al. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP , 2005, Nucleic acids research.
[21] Andrea Scaloni,et al. Activation of human T lymphocytes under conditions similar to those that occur during exposure to microgravity: A proteomics study , 2005, Proteomics.
[22] G. Tell,et al. Extracellular ATP stimulates the early growth response protein 1 (Egr-1) via a protein kinase C-dependent pathway in the human osteoblastic HOBIT cell line. , 2003, The Biochemical journal.
[23] B. Chait,et al. ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. , 2000, Analytical chemistry.
[24] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[25] B. Fredholm,et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.
[26] Q. Duh,et al. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines. , 2003, The Journal of clinical endocrinology and metabolism.
[27] S. Jhiang,et al. Inhibition of Heat Shock Protein 90, a Novel RET/PTC1-associated Protein, Increases Radioiodide Accumulation in Thyroid Cells* , 2004, Journal of Biological Chemistry.
[28] Vivek Mittal,et al. Improving the efficiency of RNA interference in mammals , 2004, Nature Reviews Genetics.
[29] Nancy Y. Ip,et al. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF , 1991, Cell.
[30] David J. Chen,et al. Two essential but distinct functions of the mammalian abasic endonuclease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[32] L. Heppel,et al. Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Insel,et al. Cellular Release of and Response to ATP as Key Determinants of the Set-Point of Signal Transduction Pathways* , 2000, The Journal of Biological Chemistry.
[34] C. Zuiani,et al. Proteomic evaluation of core biopsy specimens from breast lesions. , 2004, Cancer letters.
[35] B. Demple,et al. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. , 2005, Molecular cell.
[36] G. Burnstock,et al. Purinoceptors: are there families of P2X and P2Y purinoceptors? , 1994, Pharmacology & therapeutics.
[37] M. Romanello,et al. Mechanically induced ATP release from human osteoblastic cells. , 2001, Biochemical and biophysical research communications.
[38] A. Kamal,et al. Therapeutic and diagnostic implications of Hsp90 activation , 2004, Trends in Molecular Medicine.
[39] B. Dugué,et al. Purinergic agonist ATP is a comitogen in thyroid FRTL‐5 cells , 1996, Journal of cellular physiology.
[40] K. Suzuki,et al. Ras‐dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. , 1994, The EMBO journal.
[41] F. Sundler,et al. Presence and influence of cholinergic nerves in the human thyroid. , 1979, The Journal of clinical endocrinology and metabolism.
[42] S. Ohtaki,et al. Extracellular ATP-induced production of hydrogen peroxide in porcine thyroid cells. , 1990, The Journal of endocrinology.
[43] Richard J. Lee,et al. Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis* , 1999, The Journal of Biological Chemistry.
[44] M. Saji,et al. 17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. , 2004, The Journal of clinical endocrinology and metabolism.
[45] M. Ferrarini,et al. Unusual expression and localization of heat‐shock proteins in human tumor cells , 1992, International journal of cancer.
[46] Chih‐Chung Lin,et al. P2Y2 receptor‐mediated proliferation of C6 glioma cells via activation of Ras/Raf/MEK/MAPK pathway , 2000, British journal of pharmacology.
[47] L. Mahadevan,et al. Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.
[48] M. Karin,et al. AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.
[49] G. Burnstock,et al. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. , 2003, The Journal of investigative dermatology.
[50] A. Vertegaal. Protein kinase C-$alpha; is an upstream activator of the I$kappa;B kinase complex in the TPA signal transduction pathway to NF-$kappa;B in U2OS cells , 2000 .
[51] L. Heppel,et al. Extracellular ATP is a mitogen for 3 T 3 , 3 T 6 , and A 431 cells and acts synergistically with other growth factors ( purinoceptor / competence factor / ectoenzymes ) , 2022 .
[52] G. Burnstock,et al. P 2 X and P 2 Y purinergic receptors on human intestinal epithelial carcinoma cells : effects of extracellular nucleotides on apoptosis and cell proliferation , 2005 .
[53] J. Neary,et al. Trophic Roles of Purines and Pyrimidines , 2001 .
[54] A. Scaloni,et al. A differential proteomic approach to identify proteins associated with thyroid cell transformation. , 2005, Journal of molecular endocrinology.
[55] G. Burnstock. Purinergic Signaling and Vascular Cell Proliferation and Death , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[56] A. Muscella,et al. Disturbances in purinergic [Ca2+]i signaling pathways in a transformed rat thyroid cell line. , 2003, Cell calcium.